التفاصيل البيبلوغرافية
| العنوان: |
Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS. |
| المؤلفون: |
Turi, S, Nardelli, P, Landoni, G |
| المصدر: |
Annals of Cardiac Anaesthesia; Jul-Sep2020, Vol. 23 Issue 3, p258-259, 2p |
| مستخلص: |
Since the first cases of a different type of pneumonia in Wuhan, China in December 2019, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected more than 6.3 million people, with 376,294 confirmed deaths in 185 different countries as of June 1, 2020.[[1]] As other viruses from the Coronaviridae family, SARS-CoV-2 infection entails a systemic syndrome (COVID-19) in which respiratory symptoms represent a hallmark. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): An atypical acute respiratory distress syndrome working hypothesis. Interleukin 1 blockade with high dose intravenous anakinra in patients with COVID-19, acute respiratory distress syndrome and hyper-inflammation: A retrospective cohort study. [Extracted from the article] |
|
Copyright of Annals of Cardiac Anaesthesia is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder